Natural product-based bioactive agents in combination attenuate neuroinflammation in a tri-culture model
暂无分享,去创建一个
[1] J. Hai,et al. URB597 and Andrographolide Improve Brain Microvascular Endothelial Cell Permeability and Apoptosis by Reducing Oxidative Stress and Inflammation Associated with Activation of Nrf2 Signaling in Oxygen-Glucose Deprivation , 2022, Oxidative medicine and cellular longevity.
[2] E. Hol,et al. The neurovascular unit in leukodystrophies: towards solving the puzzle , 2022, Fluids and barriers of the CNS.
[3] Lin F. Yang,et al. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019 , 2022, The Lancet. Public health.
[4] N. Cicero,et al. Role of nutraceuticals on neurodegenerative diseases: neuroprotective and immunomodulant activity , 2021, Natural product research.
[5] T. Kanda,et al. New BBB Model Reveals That IL-6 Blockade Suppressed the BBB Disorder, Preventing Onset of NMOSD , 2021, Neurology: Neuroimmunology & Neuroinflammation.
[6] S. Dohgu,et al. Blood-Brain Barrier Dysfunction Amplifies the Development of Neuroinflammation: Understanding of Cellular Events in Brain Microvascular Endothelial Cells for Prevention and Treatment of BBB Dysfunction , 2021, Frontiers in Cellular Neuroscience.
[7] Sidharth Mehan,et al. Targeting Nrf2/HO-1 anti-oxidant signaling pathway in the progression of multiple sclerosis and influences on neurological dysfunctions , 2021 .
[8] Y. Shang,et al. Flavonoids from Scutellaria baicalensis Georgi Stems and Leaves Regulate the Brain Tau Hyperphosphorylation at M|ultiple Sites Induced by Composited Aβ in Rats. , 2021, CNS & neurological disorders drug targets.
[9] Junlei Chang,et al. Blood–Brain Barrier Breakdown: An Emerging Biomarker of Cognitive Impairment in Normal Aging and Dementia , 2021, Frontiers in Neuroscience.
[10] J. Schober,et al. NNC 26-9100 increases Aβ1-42 phagocytosis, inhibits nitric oxide production and decreases calcium in BV2 microglia cells , 2021, PloS one.
[11] Karamjeet Kaur,et al. Protective effect of andrographolide against STZ induced Alzheimer’s disease in experimental rats: possible neuromodulation and Aβ(1–42) analysis , 2021, Inflammopharmacology.
[12] Fang Ma,et al. Andrographolide ameliorates neuroinflammation in APP/PS1 transgenic mice. , 2021, International immunopharmacology.
[13] Qidi Ai,et al. The Anti-Neuroinflammatory Effect of Fuzi and Ganjiang Extraction on LPS-Induced BV2 Microglia and Its Intervention Function on Depression-Like Behavior of Cancer-Related Fatigue Model Mice , 2021, Frontiers in Pharmacology.
[14] E. D. Khilazheva,et al. Blood–Brain Barrier and Neurovascular Unit In Vitro Models for Studying Mitochondria-Driven Molecular Mechanisms of Neurodegeneration , 2021, International journal of molecular sciences.
[15] S. Vidyadaran,et al. Nitric oxide modulation in neuroinflammation and the role of mesenchymal stem cells , 2021, Experimental biology and medicine.
[16] Jiarui Wu,et al. A review on α-mangostin as a potential multi-target-directed ligand for Alzheimer's disease. , 2021, European journal of pharmacology.
[17] V. Uversky,et al. Baicalein inhibits heparin-induced Tau aggregation by initializing non-toxic Tau oligomer formation , 2021, Cell communication and signaling : CCS.
[18] S. Seto,et al. A novel tri‐culture model for neuroinflammation , 2020, Journal of neurochemistry.
[19] R. Maccioni,et al. The Emerging Role of Nutraceuticals and Phytochemicals in the Prevention and Treatment of Alzheimer's Disease. , 2020, Journal of Alzheimer's disease : JAD.
[20] Zhen Zhao,et al. G Protein-Coupled Receptors in the Mammalian Blood-Brain Barrier , 2020, Frontiers in Cellular Neuroscience.
[21] G. Zengin,et al. Nutraceuticals in Neurological Disorders , 2020, International journal of molecular sciences.
[22] John H. Zhang,et al. TREM2 activation attenuates neuroinflammation and neuronal apoptosis via PI3K/Akt pathway after intracerebral hemorrhage in mice , 2020, Journal of Neuroinflammation.
[23] Anwen Shao,et al. Neurovascular Unit Dysfunction and Neurodegenerative Disorders , 2020, Frontiers in Neuroscience.
[24] W. Banks,et al. In vitro modeling of blood–brain barrier and interface functions in neuroimmune communication , 2020, Fluids and Barriers of the CNS.
[25] K. Sirajudeen,et al. Natural Products and Their Bioactive Compounds: Neuroprotective Potentials against Neurodegenerative Diseases , 2020, Evidence-based complementary and alternative medicine : eCAM.
[26] Nicholas E. Propson,et al. Type I interferon response drives neuroinflammation and synapse loss in Alzheimer disease. , 2020, The Journal of clinical investigation.
[27] S. Rai,et al. NF-κB-Mediated Neuroinflammation in Parkinson’s Disease and Potential Therapeutic Effect of Polyphenols , 2019, Neurotoxicity Research.
[28] N. Greig,et al. Neuroinflammation as a Factor of Neurodegenerative Disease: Thalidomide Analogs as Treatments , 2019, Front. Cell Dev. Biol..
[29] Y. Tachibana,et al. Dual microglia effects on blood brain barrier permeability induced by systemic inflammation , 2019, Nature Communications.
[30] R. Maccioni,et al. Neuroinflammation as a Common Feature of Neurodegenerative Disorders , 2019, Front. Pharmacol..
[31] Chunfu Wu,et al. Baicalein administered in the subacute phase ameliorates ischemia-reperfusion-induced brain injury by reducing neuroinflammation and neuronal damage. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[32] Giulia Mantini,et al. To Combine or Not Combine: Drug Interactions and Tools for Their Analysis. Reflections from the EORTC-PAMM Course on Preclinical and Early-phase Clinical Pharmacology , 2019, AntiCancer Research.
[33] S. Bhowmick,et al. Impairment of pericyte-endothelium crosstalk leads to blood-brain barrier dysfunction following traumatic brain injury , 2019, Experimental Neurology.
[34] J. Morales-Garcia,et al. Novel Approaches for the Treatment of Alzheimer’s and Parkinson’s Disease , 2019, International journal of molecular sciences.
[35] W. Cubała,et al. Blood-brain barrier permeability and physical exercise , 2019, Journal of Neuroinflammation.
[36] Haiying Li,et al. Andrographolide ameliorates intracerebral hemorrhage induced secondary brain injury by inhibiting neuroinflammation induction , 2018, Neuropharmacology.
[37] B. Puri,et al. Leaky brain in neurological and psychiatric disorders: Drivers and consequences , 2018, The Australian and New Zealand journal of psychiatry.
[38] Hong Lu,et al. Andrographolide Protects PC12 Cells Against β-Amyloid-Induced Autophagy-Associated Cell Death Through Activation of the Nrf2-Mediated p62 Signaling Pathway , 2018, International journal of molecular sciences.
[39] R. Maccioni,et al. Alzheimer´s Disease in the Perspective of Neuroimmunology , 2018, The open neurology journal.
[40] R. Tanzi,et al. A 3D Human Tri-Culture System Modeling Neurodegeneration and Neuroinflammation in Alzheimer’s Disease , 2018, Nature Neuroscience.
[41] K. Plate,et al. Functional morphology of the blood-brain barrier in health and disease , 2018, Acta Neuropathologica.
[42] Luc Buée,et al. Tau and neuroinflammation: What impact for Alzheimer's Disease and Tauopathies? , 2018, Biomedical journal.
[43] W. Xiao,et al. In silico-based screen synergistic drug combinations from herb medicines: a case using Cistanche tubulosa , 2017, Scientific Reports.
[44] B. Zlokovic,et al. Alzheimer’s disease: A matter of blood–brain barrier dysfunction? , 2017, The Journal of experimental medicine.
[45] S. Lorkowski,et al. Optimized incubation regime for nitric oxide measurements in murine macrophages using the Griess assay. , 2017, Journal of immunological methods.
[46] G. Du,et al. Baicalein exerts anti‐neuroinflammatory effects to protect against rotenone‐induced brain injury in rats , 2017, International immunopharmacology.
[47] Zhongming Chen,et al. Reducing Neuroinflammation in Psychiatric Disorders: Novel Target of Phosphodiesterase 4 (PDE4) and Developing of the PDE4 Inhibitors , 2017 .
[48] S. Yao,et al. NLRP3 Inflammasome in Neurological Diseases, from Functions to Therapies , 2017, Front. Cell. Neurosci..
[49] Roger D. Kamm,et al. A 3D neurovascular microfluidic model consisting of neurons, astrocytes and cerebral endothelial cells as a blood-brain barrier. , 2017, Lab on a chip.
[50] Bo Wei,et al. The flavonoid baicalein rescues synaptic plasticity and memory deficits in a mouse model of Alzheimer’s disease , 2016, Behavioural Brain Research.
[51] R. Thangavel,et al. Neuroinflammation Induces Neurodegeneration. , 2016, Journal of neurology, neurosurgery and spine.
[52] Shao-Cong Sun,et al. NF-κB in inflammation and renal diseases , 2015, Cell & Bioscience.
[53] Jennifer Luebke,et al. Depletion of microglia and inhibition of exosome synthesis halt tau propagation , 2015, Nature Neuroscience.
[54] Xin Wei,et al. Increasing the Permeability of the Blood–brain Barrier in Three Different Models in vivo , 2015, CNS neuroscience & therapeutics.
[55] Mickael Guedj,et al. Analysis of drug combinations: current methodological landscape , 2015, Pharmacology research & perspectives.
[56] B. Frey,et al. Disruption in the Blood-Brain Barrier: The Missing Link between Brain and Body Inflammation in Bipolar Disorder? , 2015, Neural plasticity.
[57] N. Inestrosa,et al. Andrographolide reduces cognitive impairment in young and mature AβPPswe/PS-1 mice , 2014, Molecular Neurodegeneration.
[58] Toshio Tanaka,et al. IL-6 in inflammation, immunity, and disease. , 2014, Cold Spring Harbor perspectives in biology.
[59] P. Mecocci,et al. Nutraceuticals in cognitive impairment and Alzheimer’s disease , 2014, Front. Pharmacol..
[60] R. Maccioni,et al. Neuroinflammation in the pathogenesis of Alzheimer’s disease. A rational framework for the search of novel therapeutic approaches , 2014, Front. Cell. Neurosci..
[61] M. Oh,et al. 6-Shogaol, an active compound of ginger, protects dopaminergic neurons in Parkinson's disease models via anti-neuroinflammation , 2013, Acta Pharmacologica Sinica.
[62] M. Wolfe. The Role of Tau in Neurodegenerative Diseases and Its Potential as a Therapeutic Target , 2012, Scientifica.
[63] Dong Hyun Kim,et al. 6-Shogaol, a ginger product, modulates neuroinflammation: A new approach to neuroprotection , 2012, Neuropharmacology.
[64] Yanwei Xing,et al. Baicalin reduces the permeability of the blood-brain barrier during hypoxia in vitro by increasing the expression of tight junction proteins in brain microvascular endothelial cells. , 2012, Journal of ethnopharmacology.
[65] T. Davis,et al. Blood-brain barrier integrity and glial support: mechanisms that can be targeted for novel therapeutic approaches in stroke. , 2012, Current pharmaceutical design.
[66] B. Lin,et al. Polyphenols and neuroprotection against ischemia and neurodegeneration. , 2011, Mini reviews in medicinal chemistry.
[67] M. Oh,et al. Gami-Chunghyuldan ameliorates memory impairment and neurodegeneration induced by intrahippocampal Aβ1–42 oligomer injection , 2011, Neurobiology of Learning and Memory.
[68] N. Lee,et al. Limonene suppresses lipopolysaccharide-induced production of nitric oxide, prostaglandin E2, and pro-inflammatory cytokines in RAW 264.7 macrophages. , 2010, Journal of oleo science.
[69] R. Kuljiš,et al. The Role of Neuroimmunomodulation in Alzheimer's Disease , 2009, Annals of the New York Academy of Sciences.
[70] M. Fuente. Role of Neuroimmunomodulation in Aging , 2008 .
[71] R. Kuljiš,et al. The damage signals hypothesis of Alzheimer's disease pathogenesis. , 2008, Journal of Alzheimer's disease : JAD.
[72] D. Tsikas. Analysis of nitrite and nitrate in biological fluids by assays based on the Griess reaction: appraisal of the Griess reaction in the L-arginine/nitric oxide area of research. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[73] E. Benarroch. Neurovascular unit dysfunction: A vascular component of Alzheimer disease? , 2007, Neurology.
[74] L. Marsh,et al. Non-dopaminergic treatment of cognitive impairment and dementia in Parkinson's disease: A review , 2006, Journal of the Neurological Sciences.
[75] M. Block,et al. Microglia and inflammation-mediated neurodegeneration: Multiple triggers with a common mechanism , 2005, Progress in Neurobiology.
[76] Berislav V. Zlokovic,et al. Neurovascular mechanisms of Alzheimer's neurodegeneration , 2005, Trends in Neurosciences.
[77] G. Johnson,et al. Tau phosphorylation in neuronal cell function and dysfunction , 2004, Journal of Cell Science.
[78] A. S. Hamzah,et al. Evaluation of antioxidant and nitric oxide inhibitory activities of selected Malaysian medicinal plants. , 2004, Journal of ethnopharmacology.
[79] Xueji Zhang,et al. Measurement of Nitric Oxide Production in Biological Systems by Using Griess Reaction Assay , 2003 .
[80] Tony Wyss-Coray,et al. Inflammation in Neurodegenerative Disease—A Double-Edged Sword , 2002, Neuron.
[81] W. Mayhan. Cellular mechanisms by which tumor necrosis factor-α produces disruption of the blood–brain barrier , 2002, Brain Research.
[82] K. Audus,et al. Nitric oxide and blood-brain barrier integrity. , 2001, Antioxidants & redox signaling.
[83] J L West,et al. Nitric oxide-generating polymers reduce platelet adhesion and smooth muscle cell proliferation. , 2000, Biomaterials.
[84] Patrick R. Hof,et al. Tau protein isoforms, phosphorylation and role in neurodegenerative disorders 1 1 These authors contributed equally to this work. , 2000, Brain Research Reviews.
[85] T. Nikaido,et al. [The study of Chinese herbal medicinal prescription with enzyme inhibitory activity. V. The study of hange-shashin-to, kanzo-shashin-to, shokyo-shashin-to with adenosine 3',5'-cyclic monophosphate phosphodiesterase]. , 1991, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.
[86] S. Moncada,et al. Nitric oxide: physiology, pathophysiology, and pharmacology. , 1991, Pharmacological reviews.